Abbott Laboratories engages in the discovery ... The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular ...

and Abbott (NYSE: ABT). With a proven track record of driving revenue growth, expanding market share, and fostering strategic partnerships, he will play a critical role in scaling Cagent Vascular ...